Natriuretic Peptides in Congestive Heart Failure
Published January 14, 2016
|
19 min
    Download
    Add to queue
    Copy URL
    Show notes
    BNP use as a lab and therapeutic are discussed. The episode also explores the PARADIGM-HF trial and Neprilysin inhibition. The novel combination medication sacubitril/valsartan (Entresto) for systolic CHF is evaluated in depth. Clinical tips for avoiding angioedema and other clinical pearls are provided.
      15
      15
        0:00:00 / 0:00:00